Position in AUPH
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$741,000
+$345,440 QoQ
Shares Held
50,000
+101.6% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Marex Group plc holds $88,179,553 across 55 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TGTX |
Tg Therapeutics, Inc.
|
276,178 | $15,173,219 | |
| 2 | SANA |
Sana Biotechnology, Inc.
|
3,989,100 | $13,921,959 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
623,600 | $10,551,312 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
170,584 | $9,303,650 | |
| 5 | DNLI |
Denali Therapeutics Inc.
|
295,631 | $7,603,629 | |
| 6 | MRNA |
Moderna, Inc.
|
88,575 | $6,202,907 | |
| 7 | QURE |
uniQure N.V.
|
81,500 | $3,753,890 | |
| 8 | ABVX |
Abivax S.A.
|
27,336 | $3,642,795 |
All Filings in AUPH
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $741,000 | 50,000 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $395,560 | 24,800 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $994,500 | 90,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,143,450 | 135,000 | Shares | Defined | 2025-08-19 | |
| 2025-03-31 | $2,412,000 | 300,000 | Shares | Defined | 2026-04-02 | |
| 2024-12-31 | $2,604,200 | 290,000 | Shares | Defined | 2026-04-02 | |
| 2024-09-30 | $3,591,700 | 490,000 | Shares | Defined | 2026-04-07 | |
| 2024-06-30 | $1,713,000 | 300,000 | Shares | Defined | 2026-04-02 | |
| 2024-03-31 | $1,503,000 | 300,000 | Shares | Defined | 2026-04-02 | |
| 2023-12-31 | $3,191,450 | 355,000 | Shares | Defined | 2026-04-02 | |
| No filing history on record for this holder in this stock. | ||||||